Plasminogen activator
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
===3D structures of plasminogen activator=== | ===3D structures of plasminogen activator=== | ||
| + | |||
| + | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
[[1a5i]] – PLA residues 213-477 + EGR-CMK – Vampire bat<br /> | [[1a5i]] – PLA residues 213-477 + EGR-CMK – Vampire bat<br /> | ||
| Line 17: | Line 19: | ||
[[1bda]] – hTPA catalytic domain (mutant) + EGR-CMK<br /> | [[1bda]] – hTPA catalytic domain (mutant) + EGR-CMK<br /> | ||
[[1pk2]] – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR<br /> | [[1pk2]] – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR<br /> | ||
| - | [[1tpk]] - hTPA kringle 2 domain<br /> | + | [[1tpk]], [[1pml]] - hTPA kringle 2 domain<br /> |
| + | [[1kdu]] - hTPA kringle domain – NMR<br /> | ||
[[1tpm]], [[1tpn]] - hTPA fibrin-binding domain – NMR | [[1tpm]], [[1tpn]] - hTPA fibrin-binding domain – NMR | ||
Revision as of 09:02, 9 April 2014
Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.
Contents |
3D structures of plasminogen activator
Updated on 09-April-2014
1a5i – PLA residues 213-477 + EGR-CMK – Vampire bat
1bqy – PLA – Pit viper
Tissue plasminogen activator
1a5h – hTPA HC+LC + benzamidine – human
1rtf - hTPA HC+LC
1tpg – hTPA F1-G - NMR
1bda – hTPA catalytic domain (mutant) + EGR-CMK
1pk2 – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR
1tpk, 1pml - hTPA kringle 2 domain
1kdu - hTPA kringle domain – NMR
1tpm, 1tpn - hTPA fibrin-binding domain – NMR
